Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OriolaCHIX:ORIOLH 35 3-Year FCF Growth Rate is -7.00% as of Jun. 2026. GuruFocus rates CHIX:ORIOLH with a GF Score™ of 35/100 and a GF Value™ of €0.73. The stock has 5 warning signs investors should review. Among 466 Healthcare Providers & Services companies, Oriola ranks worse than 72.75% on this metric.
During the past 12 months, Oriola's average Free Cash Flow per Share Growth Rate was -109.30% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was -7.00% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 8.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Oriola was 143.80% per year. The lowest was -67.80% per year. And the median was 10.65% per year.
Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.
For the Pharmaceutical Retailers subindustry, Oriola's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oriola 3-Year FCF Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Oriola's 3-Year FCF Growth Rate distribution charts can be found below:
* The bar in red indicates where Oriola's 3-Year FCF Growth Rate falls into.
This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
What does a 3-Year FCF Growth Rate of -7.00% mean?
Oriola (CHIX:ORIOLH) has a 3-Year FCF Growth Rate of -7.00% as of Jun. 2026. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for Oriola and its competitors. According to the industry distribution chart, Oriola ranks #339 out of 466 companies in the Healthcare Providers & Services industry, placing it in the top 72.7%.
Is Oriola's 3-Year FCF Growth Rate too high?
Oriola's current 3-Year FCF Growth Rate is -7.00%. Based on the distribution chart, Oriola ranks #339 out of 466 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Oriola has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Oriola's 3-Year FCF Growth Rate compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Oriola ranks #339 out of 466 companies for 3-Year FCF Growth Rate. This places Oriola in the lower half of its industry. The industry median 3-Year FCF Growth Rate is 12.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year FCF Growth Rate for a Healthcare Providers & Services company?
The median 3-Year FCF Growth Rate among Healthcare Providers & Services companies is 12.65, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year FCF Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year FCF Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year FCF Growth Rate mean?
A high 3-Year FCF Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for Oriola and its competitors. For the Healthcare Providers & Services industry, the median 3-Year FCF Growth Rate is 12.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oriola's current 3-Year FCF Growth Rate is -7.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oriola stock overvalued right now?
Oriola (CHIX:ORIOLH) has a current 3-Year FCF Growth Rate of -7.00%. The stock's GF Value™ is €0.73, compared to a current price of €0.94 — trading 28.5% above its estimated fair value. The current 3-Year FCF Growth Rate is -7.00%. Oriola's overall GF Score™ is 35/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year FCF Growth Rate calculated?
3-Year FCF Growth Rate is calculated from a company's financial statements. For Oriola (CHIX:ORIOLH), the current 3-Year FCF Growth Rate is -7.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oriola (CHIX:ORIOLH) Overvalued in 2026?
Based on GuruFocus' analysis, Oriola stock appears to be overvalued.
The current stock price of €0.94 is trading 28.5% above its estimated GF Value™ of €0.73.
Key valuation signals for CHIX:ORIOLH:
3-Year FCF Growth Rate: -7.00%
GF Value™: €0.73 vs. price of €0.94 (28.5% above fair value)
No single metric tells the full story. See the CHIX:ORIOLH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oriola Corp is a health and wellbeing company operating in Nordic countries. It offers services such as the distribution of pharmaceuticals and other health and well-being products, services, and dose dispensing. Oriola's operations are divided into two segments which include distribution and wholesale. Geographically, the company operates in Sweden, Finland and other countries generating majority revenue from the region of Sweden.
35GF Score
Get the complete analysis for CHIX:ORIOLH
3-Year FCF Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:ORIOLH has been successfully added to your 
